共 78 条
[1]
Newburger JW(2014)Guidelines for medical treatment of acute Kawasaki disease: report of the research Committee of the Japanese Society of pediatric cardiology and cardiac surgery (2012 revised version) Pediatr Int 56 135-158
[2]
Takahashi M(2004)Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, Endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association Pediatrics 114 1708-1733
[3]
Gerber MA(2016)Serum Tenascin-C as a novel predictor for risk of coronary artery lesion and resistance to intravenous immunoglobulin in Kawasaki disease- a multicenter retrospective study Circ J 80 2376-2381
[4]
Gewitz MH(2010)Effect of intravenous immunoglobulin on neutrophil in patients with Kawasaki's disease Zhongguo Dang Dai Er Ke Za Zhi 12 991-992
[5]
Tani LY(2015)Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease Circ J 79 1349-1356
[6]
Burns JC(1998)A predictive instrument for coronary artery aneurysms in Kawasaki disease: US multicenter Kawasaki disease study group Am J Cardiol 81 1116-1120
[7]
Shulman ST(2013)Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China Pediatr Infect Dis J 32 e397-e402
[8]
Bolger AF(2009)Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age Eur J Pediatr 168 1315-1321
[9]
Ferrieri P(2002)Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease Eur J Pediatr 161 105-111
[10]
Baltimore RS(2003)Prognostic impact of vascular leakage in acute Kawasaki disease Circulation 108 325-330